Evidence map›Paper›PMID 38062063›Full record

ArticleScientific reports2023

CBLL1 is hypomethylated and correlates with cortical thickness in transgender men before gender affirming hormone treatment.

Rosa Fernández, Leire Zubiaurre-Elorza, Andrea Santisteban, Natalia Ojeda, Sarah Collet, Meltem Kiyar, Guy T'Sjoen, Sven C Mueller, Antonio Guillamon, Eduardo Pásaro

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Rosa Fernández *Centro Interdisciplinar de Química E Bioloxía - CICA. Departamento de Psicología, Universidade da Coruña, Grupo DICOMOSA, Campus Elviña S/N, 15071, A Coruña, Spain. rosa.fernandez@udc.es.
Leire Zubiaurre-Elorza *Departamento de Psicología, Facultad de Ciencias de la Salud, Universidad de Deusto, Bilbao, Spain.
Andrea SantistebanCentro Interdisciplinar de Química E Bioloxía - CICA. Departamento de Psicología, Universidade da Coruña, Grupo DICOMOSA, Campus Elviña S/N, 15071, A Coruña, Spain.
Natalia OjedaDepartamento de Psicología, Facultad de Ciencias de la Salud, Universidad de Deusto, Bilbao, Spain.
Sarah ColletDepartment of Endocrinology, Ghent University Hospital, 9000, Ghent, Belgium.
Meltem KiyarDepartment of Experimental Clinical and Health Psychology, Ghent University, 9000, Ghent, Belgium.
Guy T'SjoenDepartment of Endocrinology, Center for Sexology and Gender, Ghent University Hospital, 9000, Ghent, Belgium.
Sven C MuellerDepartment of Experimental Clinical and Health Psychology, Ghent University, 9000, Ghent, Belgium.
Antonio GuillamonDepartamento de Psicobiología, Facultad de Psicología, Universidad Nacional de Educación a Distancia, 28040, Madrid, Spain. aguillamon@psi.uned.es.
Eduardo PásaroCentro Interdisciplinar de Química E Bioloxía - CICA. Departamento de Psicología, Universidade da Coruña, Grupo DICOMOSA, Campus Elviña S/N, 15071, A Coruña, Spain.
Ghent University Hospital · BEUniversidade da Coruña · ESUniversidad de Deusto · ESNational University of Distance Education · ES

Funding

Ministerio de Ciencia, Innovación y Universidades PGC2018-094919-B-C21Ministerio de Ciencia, Innovación y Universidades PGC2018-094919-B-C22Special Research Fund (BOF) of Ghent University IOP003- 18Xunta de Galicia ED431B 2022/16
6 · The paper itself

Abstract

Gender identity refers to the consciousness of being a man, a woman or other condition. Although it is generally congruent with the sex assigned at birth, for some people it is not. If the incongruity is distressing, it is defined as gender dysphoria (GD). Here, we measured whole-genome DNA methylation by the Illumina © Infinium Human Methylation 850k array and reported its correlation with cortical thickness (CTh) in 22 transgender men (TM) experiencing GD versus 25 cisgender men (CM) and 28 cisgender women (CW). With respect to the methylation analysis, TM vs. CW showed significant differences in 35 CpGs, while 2155 CpGs were found when TM vs. CM were compared. With respect to correlation analysis, TM showed differences in methylation of CBLL1 and DLG1 genes that correlated with global and left hemisphere CTh. Both genes were hypomethylated in TM compared to the cisgender groups. Early onset TM showed a positive correlation between CBLL1 and several cortical regions in the frontal (left caudal middle frontal), temporal (right inferior temporal, left fusiform) and parietal cortices (left supramarginal and right paracentral). This is the first study relating CBLL1 methylation with CTh in transgender persons and supports a neurodevelopmental hypothesis of gender identity.

Indexed as

Transgender PersonsTranssexualismAdolescentAdultFemaleGender IdentityHormonesHumansMaleMethylationUbiquitin-Protein LigasesYoung AdultCBLL1 protein, humanHormonesUbiquitin-Protein Ligases

Identifiers

PMID38062063
PMCPMC10703770
OpenAlexW4389433933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.